First-in-human study assessing safety, tolerability, and pharmacokinetics of 2-hydroxybenzylamine acetate, a selective dicarbonyl electrophile scavenger, in healthy volunteers.
BMC Pharmacol Toxicol
; 20(1): 1, 2019 Jan 05.
Article
in En
| MEDLINE
| ID: mdl-30611293
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Benzylamines
/
Neuroprotective Agents
/
Dietary Supplements
/
Acetates
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
BMC Pharmacol Toxicol
Year:
2019
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Reino Unido